Genes, Locations and Genetic Disorders on Chromosome 19

Last Updated: Sun Aug 6 22:00:02 EDT 2000
GeneGDB AccessionIDLocationOMIM Link
AD2 GDB:11874819pter-19qter ALZHEIMER DISEASE-2; AD2
AMH GDB:11899619p13.3-19p13.3 PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS
ANTI-MULLERIAN HORMONE; AMH
APOC2 GDB:11968919q13.2-19q13.2 APOLIPOPROTEIN C-II DEFICIENCY, TYPE I HYPERLIPOPROTEINEMIA DUE TO
APOE GDB:11969119q13.2-19q13.2 APOLIPOPROTEIN E; APOE
ATHS GDB:12880319p13.3-19p13.2 LIPOPROTEIN PHENOTYPE; ALP
BAX GDB:22808219q13.3-19q13.4 BCL2-ASSOCIATED X PROTEIN; BAX
BCKDHA GDB:11972319q13.2-19q13.2 MAPLE SYRUP URINE DISEASE
BCL3 GDB:12056119q13.2-19q13.2 B-CELL LEUKEMIA/LYMPHOMA-3; BCL3
BFIC GDB:995458419q-19q BENIGN FAMILIAL INFANTILE CONVULSIONS
C3 GDB:11904419p13.3-19p13.3 COMPLEMENT COMPONENT-3; C3
CACNA1A GDB:12643219p13-19p13 19p13.1-19p13.1 ATAXIA, PERIODIC VESTIBULOCEREBELLAR
HEMIPLEGIC MIGRAINE, FAMILIAL; MHP
SPINOCEREBELLAR ATAXIA 6; SCA6
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA 1A SUBUNIT; CACNA1A
CCO GDB:11975519q12-19q13.1 CENTRAL CORE DISEASE OF MUSCLE
CEA GDB:11905419q13.2-19q13.2 CARCINOEMBRYONIC ANTIGEN; CEA
COMP GDB:34426319pter-19qter 19p13.1-19p13.1 PSEUDOACHONDROPLASTIC DYSPLASIA
CARTILAGE OLIGOMERIC MATRIX PROTEIN; COMP
CRX GDB:33393219q13.3-19q13.4 19q13.3-19q13.3 CONE-ROD DYSTROPHY-2; CORD2
CONE-ROD HOMEO BOX-CONTAINING GENE
DBA GDB:960035319q13.2-19q13.2 ANEMIA, CONGENITAL HYPOPLASTIC, OF BLACKFAN AND DIAMOND
DFNA4 GDB:60654019q13-19q13 DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL, 4; DFNA4
DLL3 GDB:995902619q13.1-19q13.3 VERTEBRAL ANOMALIES
DMPK GDB:11909719q13.3-19q13.3 DYSTROPHIA MYOTONICA; DM
DMWD GDB:717835419q13.3-19q13.3 DYSTROPHIA MYOTONICA; DM
E11S GDB:11910119q13.1-19q13.3 ECHO 11 SENSITIVITY; E11S
EDM1 GDB:30753919pter-19qter EPIPHYSEAL DYSPLASIA, MULTIPLE; MED
EPOR GDB:12524219p13.2-19p13.2 ERYTHROPOIETIN RECEPTOR; EPOR
ERCC2 GDB:11911219q13.2-19q13.2 19q13.2-19q13.3 19q13.3-19q13.3 EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; ERCC2
XERODERMA PIGMENTOSUM IV; XP4
ETFB GDB:11988719q13.3-19q13.3 19q13.4-19q13.4 ELECTRON TRANSFER FLAVOPROTEIN, BETA POLYPEPTIDE; ETFB
EXT3 GDB:38378019p-19p EXOSTOSES, MULTIPLE, TYPE III; EXT3
EYCL1 GDB:11926919q12-19q13 19pter-19qter EYE COLOR-1; EYCL1
FTL GDB:11923419q13.3-19q13.4 FERRITIN LIGHT CHAIN; FTL
FUT1 GDB:12061819q13.3-19q13.3 FUCOSYLTRANSFERASE-1; FUT1
FUT2 GDB:12061919q13.3-19q13.3 FUCOSYLTRANSFERASE-2; FUT2
FUT6 GDB:13518019p13.3-19p13.3 FUCOSYLTRANSFERASE-6; FUT6
GAMT GDB:131373619p13.3-19p13.3 GUANIDINOACETATE METHYLTRANSFERASE; GAMT
GCDH GDB:13600419p13.2-19p13.2 GLUTARICACIDEMIA I
GPI GDB:12001519q13.1-19q13.1 GLUCOSEPHOSPHATE ISOMERASE; GPI
GUSM GDB:11929119pter-19qter GLUCURONIDASE, MOUSE, MODIFIER OF; GUSM
HB1 GDB:995458619q13.2-19q13.3 BUNDLE BRANCH BLOCK
HCL1 GDB:11930419q12-19q13 19pter-19qter HAIR COLOR-1; HCL1
HHC2 GDB:24983619p-19p HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2
HHC3 GDB:995512119q13-19q13 HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3
ICAM3 GDB:13623619p13.3-19p13.2 INTERCELLULAR ADHESION MOLECULE-3; ICAM3
INSR GDB:11935219p13.2-19p13.2 19p13.3-19p13.3 INSULIN RECEPTOR; INSR
JAK3 GDB:37646019p13.1-19p12 19p13.1-19p13.1 JANUS KINASE 3 JAK3
KLK3 GDB:11969519q13.3-19q13.3 ANTIGEN, PROSTATE-SPECIFIC; APS
LDLR GDB:11936219p13.2-19p13.2 HYPERCHOLESTEROLEMIA, FAMILIAL; FHC
LHB GDB:11936419q13.3-19q13.3 LUTEINIZING HORMONE, BETA POLYPEPTIDE; LHB
LIG1 GDB:12727419q13.3-19q13.3 LIGASE I, DNA, ATP-DEPENDENT; LIG1
LOH19CR1 GDB:983748219q13-19q13 ANEMIA, CONGENITAL HYPOPLASTIC, OF BLACKFAN AND DIAMOND
LYL1 GDB:12015819p13.2-19p13.2 LEUKEMIA, LYMPHOID, 1; LYL1
MAN2B1 GDB:11937619cen-19cen MANNOSIDOSIS, ALPHA B, LYSOSOMAL
MDRV GDB:630671419p13.3-19p13.3 MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV
MLLT1 GDB:13679119p13.3-19p13.3 MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 1; MLLT1
NOTCH3 GDB:36116319p-19p 19q12-19q12 19p13.2-19p13.1 DEMENTIA, HEREDITARY MULTI-INFARCT TYPE
NOTCH, DROSOPHILA, HOMOLOG OF, 3; NOTCH3
NPHS1 GDB:34210519q12-19q13.1 NEPHROSIS 1, CONGENITAL, FINNISH TYPE; NPHS1
OFC3 GDB:12806019q13-19q13 OROFACIAL CLEFT-3; OFC3
OPA3 GDB:995459019q13.2-19q13.3 OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA
PEPD GDB:12027319cen-19q13.11 19q13.1-19q13.1 PEPTIDASE D; PEPD
PLOSL GDB:983600519q13.1-19q13.1 POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY
PRTN3 GDB:12687619p13.3-19p13.3 PROTEINASE 3; PRTN3; PR3
PSG1 GDB:12032119q13.2-19q13.2 PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 1; PSG1
PVR GDB:12032419q13.2-19q13.2 POLIOVIRUS SUSCEPTIBILITY, OR SENSITIVITY; PVS
RP11 GDB:33391119q13.4-19q13.4 RETINITIS PIGMENTOSA 11; RP11
RYR1 GDB:12035919q12-19q13.2 19q13.1-19q13.1 HYPERTHERMIA OF ANESTHESIA
RYANODINE RECEPTOR-1; RYR1
SLC5A5 GDB:589218419p13.2-19p12 SOLUTE CARRIER FAMILY 5, MEMBER 5; SLC5A5
SLC7A9 GDB:995885219q13.1-19q13.1 CYSTINURIA, TYPE III; CSNU3
STK11 GDB:973238319p13.3-19p13.3 PEUTZ-JEGHERS SYNDROME
SERINE/THREONINE PROTEIN KINASE 11; STK11
TBXA2R GDB:12751719p13.3-19p13.3 THROMBOXANE A2 RECEPTOR, PLATELET; TBXA2R
TNNI3 GDB:12530919p13.2-19q13.2 19q13.4-19q13.4 TROPONIN I, CARDIAC; TNNI3